Erythropoietin Receptor Signaling through STAT3 Is Required for Glioma Stem Cell Maintenance

Recombinant erythropoietin (EPO) is a growth factor used in the treatment of chemotherapy-induced anemia, but recent studies suggest that EPO may accelerate cancer growth. Although several cancers express EPO receptors (EPORs), the mechanism by which EPOR promotes tumor growth remains poorly underst...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Cao, Yiting, Lathia, Justin D., Eyler, Christine E., Wu, Qiulian, Li, Zhizhong, Wang, Hui, McLendon, Roger E., Hjelmeland, Anita B., Rich, Jeremy N.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: SAGE Publications 2010
Aiheet:
Original Articles and Short Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2906804/
https://ncbi.nlm.nih.gov/pubmed/20657792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1947601909356352
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia